Martin Comberbach

Title: Martin Comberbach: Innovator in Hepatitis B Vaccine Development

Introduction

Martin Comberbach is a notable inventor based in La Hulpe, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines for hepatitis B. His innovative work has led to the creation of a patent that addresses critical aspects of vaccine formulation.

Latest Patents

Comberbach holds a patent titled "Antigens and methods therefor." This patent describes a composite particle that includes at least two polypeptides corresponding to all or part of a protein with biological activity related to hepatitis B surface antigens. The composite particle presents at least two antigenic determinants provided by the S-protein, preS2-protein, or preS1-protein. Additionally, the invention includes a modified hepatitis B surface antigen L protein, which can be used alone or incorporated into these composite particles. A specific embodiment of the modified L protein (L*) comprises residues 12-52, followed by residues 133-145 and residues 175-400 of the L protein. The patent suggests that improved hepatitis B vaccines may be developed through the expression of these immunogens, particularly in yeast such as S. cerevisiae and Hansenula polymorpha.

Career Highlights

Martin Comberbach is associated with Smithkline Biologicals, S.A., where he has contributed to various research initiatives. His work has focused on enhancing vaccine efficacy and safety, which is crucial in the fight against infectious diseases.

Collaborations

Comberbach has collaborated with notable colleagues, including Nigel Harford and Teresa Cabezon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of vaccine development.

Conclusion

Martin Comberbach's contributions to hepatitis B vaccine development through his patent demonstrate his commitment to advancing medical science. His innovative approaches and collaborations continue to impact the field positively.